1. Antibiotic uptake into gram-negative bacteria

   • R. E. W. Hancock
   • A. Bell

   Review Pages: 713 - 720

2. Antiviral therapy with small particle aerosols

   • V. Knight
   • B. Gilbert

   Review Pages: 721 - 731

3. The new generation of antifungal drugs

   • D. A. Stevens

   Editorial Pages: 732 - 735

4. Contribution of granulocytes and monocytes to resistance against experimental disseminatedCandida albicans infection

   • J. W. van 't Wout
   • I. Linde
   • R. van Furth

   Article Pages: 736 - 741

5. Value of surveillance cultures in the management of neutropenic patients

   • M. A. Daw
   • P. Munnelly
   • C. T. Keane

   Article Pages: 742 - 747

6. Prospective evaluation of the Gen-Probe assay for detection of Legionellae in respiratory specimens

   • B. N. Doebbeling
   • M. J. Bale
   • M. A. Pfaller

   Article Pages: 748 - 752

7. Mouse model for evaluation of antibiotic treatment of acute and chronic infections

   • J. Renneberg
   • M. Walder

   Article Pages: 753 - 757

8. Comparison of four commercial microdilution systems for susceptibility testing of anaerobic bacteria

   • W. Heizmann
   • H. Werner
   • B. Herb

   Article Pages: 758 - 763

9. Serum antibody response to filamentous hemagglutinin in patients with clinical pertussis measured by an enzyme-linked immunosorbent assay

   • G. Zackrisson
   • F. Arminjon
   • B. Trollfors

   Article Pages: 764 - 770

10. Comparative evaluation of RapID ANA and API 20A for identification of anaerobic bacteria

    • P. Summanen
    • H. Jousimies-Somer

    Article Pages: 771 - 775

11. Emergence of bacterial resistance to cefamandole in vivo due to outer membrane protein deficiency

    • J. A. M. van de Klundert
    • M. H. van Gestel
    • S. de Marie

    Notes Pages: 776 - 778

12. Synergistic effect of dosage and bacterial inoculum in TEM-1 mediated antibiotic resistance

    • J. A. Reguera
    • F. Baquero
    • J. L. Martinez

    Notes Pages: 778 - 779

13. Dissemination in five French hospitals ofKlebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam

    • A. Bure
    • P. Legrand
    • A. Philippon

    Notes Pages: 780 - 782

14. Nosocomial bacteremia caused byBacillus species

    • V. Richard
    • P. Van der Auwera
    • F. Meunier

    Notes Pages: 783 - 785

15. High prevalence of tuberculosis in AIDS patients in Spain

    • E. Bouza
    • C. Martín-Scapa
    • M. J. Sagues-Cifuentes

    Notes Pages: 785 - 788

16. Serological study of meningococcal isolates in Switzerland and France 1980–1986

    • P. Calain
    • J. Poolman
    • B. Hirschel

    Notes Pages: 788 - 791

17. Efficacy of the Enteric Pathogen Screen card in the presumptive identification ofSalmonella enteritidis

    • J. Reina
    • L. Torrens
    • P. Alomar

    Notes Pages: 791 - 793

18. In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101

    • A. L. Barry
    • K. E. Aldridge
    • M. A. Pfaller

    New Antimicrobial Agents Pages: 794 - 798

19. Comparative in vitro activity of A-56268

    • A. M. Sefton
    • J. P. Maskell
    • J. D. Williams

    New Antimicrobial Agents Pages: 798 - 802

20. Ceftibuten (7432-S, SCH 39720): Comparative antimicrobial activity against 4735 clinical isolates, beta-lactamase stability and broth microdilution quality control guidelines

    • R. N. Jones
    • A. L. Barry
    • The Collaborative Antimicrobial Susceptibility Testing Group

    New Antimicrobial Agents Pages: 802 - 807

21. In vitro interaction between the penem FCE 22101 and ceftazidime

    • A. L. Barry
    • R. N. Jones

    New Antimicrobial Agents Pages: 807 - 809

22. Turbidimetric response ofStaphylococcus aureus andEnterococcus faecalis to daptomycin

    • M. C. J. Wale
    • L. J. Wale
    • D. Greenwood

    New Antimicrobial Agents Pages: 809 - 812

23. In vitro activity of new antibiotics againstHaemophilus influenzae

    • K. Machka
    • H. Balg
    • I. Braveny

    New Antimicrobial Agents Pages: 812 - 814

24. Absence of antibodies to HTLV-I/II in French patients with hematological malignancies

    • G. Agius
    • V. Vaillant
    • M. Castets

    Letter To The Editor Pages: 815 - 816

25. Isolation of human immunodeficiency virus type 2 from a homosexual man in Belgium

    • B. Vanderborght
    • R. J. De Leys
    • H. Van Heuverswyn

    Letter To The Editor Pages: 816 - 818

26. Isolation offlavobacterium thalpophilum from a wound

    • W. Hansen
    • J. Freney
    • B. Holmes

    Letter To The Editor Pages: 818 - 819

27. In vitro evaluation of Ramoplanin (MDL 62198, A 16686)

    • S. Dixson
    • W. Brumfitt
    • J. M. T. Hamilton-Miller

    Letter To The Editor Pages: 819 - 821

28. Esterase iso-enzyme electrophoresis for epidemiological surveillance ofPseudomonas aeruginosa hospital infections

    • S. Pattyn
    • G. Mertens

    Letter To The Editor Pages: 821 - 822

29. Enhancement of yield ofChlamydia trachomatis Hela 229 cell culture

    • J. T. H. Wagenvoort
    • T. van Rijsoort-Vos
    • E. Stolz

    Letter To The Editor Pages: 822 - 822

30. Third European congress on anaerobic bacteria and infections Munich, FRG — March 8–10, 1989

    Report Pages: 825 - 826

31. 1st announcement

    Announcement Pages: 827 - 829

32. Announcements

    Announcement Pages: 830 - 830